Infectious Diseases Group Publications

Chandrahasen C, Grimwood K, Redshaw N, Rich FJ, Wood C, Stanley J, Kirman JR (2010) Geographical differences in the proportion of human group A rotavirus strains within New Zealand during one epidemic season.  J Med Virol 82:897-902

Grimwood K, Cohet C, Rich FJ, Cheng S, Wood C, Redshaw N, Cunningham CW, Pearce N, Kirman JR (2008) Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand. Epidemiol Infect, 136:1333-41

Quinn KM, Rich FJ, Goldsack LM, de Lisle GW, Buddle BM, Delahunt B, Kirman JR (2008) Accelerating the secondary immune response by inactivating CD4+CD25+ T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis. Eur J Immunol, 38:695-705 

Goldsack L, Kirman JR (2007) Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis. Tuberculosis (Edinb), 87:465-73

Redshaw N, Wood C, Rich F, Grimwood K, Kirman JR (2007) Human bocavirus in infants, New Zealand. Emerg Infect Dis, 13:1797-9 

Matheson J, Rich F, Cohet C, Grimwood K, Huang QS, Penny D, Hendy M, Kirman J (2006) Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years. J Med Virol, 78:1354-64

Quinn K, McHugh R, Rich F, Goldsack L, de Lisle G, Buddle BM, Delahunt B, Kirman J (2006) Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load. Immunol Cell Biol, 84:467-74

Kirman JR, Seder RA (2003) DNA vaccination: the answer to stable, protective T-cell memory? Curr Opin Immunol, 15:471-6

Kirman J, Turon T, Hua S, Li A, Kraus C, Polo JM, Belisle J, Morris S, Seder RA (2003) Enhanced immunogenicity to Mycobacterium tuberculosis by vaccinating with an alphavirus plasmid replicon expressing antigen 85A. Infect Immun, 71:575-9

Shah J, Darrah P, Ambrozak D, Turon T, Mendez S, Kirman J, Wu CY, Glaichenhaus N, Seder RA (2003) Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice. J Exp Med, 198:281-91